BRIEF published on 08/16/2024 at 15:18, 3 months 8 days ago The Vanguard Group Discloses Position in Britvic plc Form 8.3 Britvic Plc Takeover Code Securities Disclosure Vanguard Group
PRESS RELEASE published on 08/16/2024 at 15:13, 3 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses a 5.47% stake in Britvic plc as of 15 August 2024. Details included in the Form 8.3 filing Form 8.3 Britvic Plc Vanguard Group Financial Disclosure Stake Disclosure
BRIEF published on 08/15/2024 at 15:15, 3 months 9 days ago The Vanguard Group Reports Open Position in Britvic plc Form 8.3 Britvic Plc Takeover Code Vanguard Group Stock Disclosure
PRESS RELEASE published on 08/15/2024 at 15:10, 3 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses 5.47% stake in Britvic plc as of 14 Aug 2024. Purchase transaction of 1,233 shares at 12.69 GBP per share Britvic Plc Vanguard Group Stock Market Stake Disclosure Purchase Transaction
BRIEF published on 08/14/2024 at 15:10, 3 months 10 days ago The Vanguard Group, Inc. Discloses Position in Britvic Plc Securities Disclosure Takeover Code Vanguard Britvic
PRESS RELEASE published on 08/14/2024 at 15:05, 3 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses a 5.47% stake in Britvic plc, as of 13th August 2024, through 13,605,082 ordinary securities The Vanguard Group, Inc. Britvic Plc Stake Disclosure 5.47% 13,605,082 Securities
BRIEF published on 08/12/2024 at 15:32, 3 months 12 days ago The Vanguard Group, Inc.'s Current Position in Britvic plc Explained Takeover Code Securities Disclosure Vanguard Group Stock Transactions Britvic
PRESS RELEASE published on 08/12/2024 at 15:27, 3 months 12 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses 5.46% ownership of Britvic plc in Form 8.3 filing on 12-Aug-2024 Form 8.3 Britvic Plc Vanguard Group Ownership Disclosure Stock Holdings
BRIEF published on 08/09/2024 at 15:54, 3 months 15 days ago Form 8.3 Disclosure: The Vanguard Group's Position in Britvic plc Securities Disclosure Takeover Code Vanguard Group Britvic
PRESS RELEASE published on 08/09/2024 at 15:49, 3 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. disclosed a 5.47% stake in Britvic plc as of 08 August 2024, according to Form 8.3 filing under the Takeover Code Form 8.3 Britvic Plc Takeover Code Vanguard Group Stake Disclosure
Published on 11/25/2024 at 04:00, 2 hours 11 minutes ago Tanzania Safaris Unveils New Luxury Adventure Packages for 2025
Published on 11/22/2024 at 23:55, 2 days 6 hours ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 2 days 6 hours ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 2 days 7 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/24/2024 at 19:16, 10 hours 55 minutes ago EQS-Adhoc: RENK Group AG: Termination of mandate of CEO Susanne Wiegand and appointment of Dr. Alexander Sagel as CEO
Published on 11/24/2024 at 19:07, 11 hours 4 minutes ago EQS-Adhoc: ABO Energy KGaA reduces forecast for the 2024 annual result to EUR 20 to 25 million and confirms market expectation for the 2025 financial year
Published on 11/22/2024 at 18:14, 2 days 11 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 2 days 12 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 06:58, 3 days 23 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 4 days 10 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 4 days 12 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 4 days 12 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
